Stavzor Alternatives Compared
| Stavzor (valproic acid) | Caplyta (lumateperone) | Lamictal (lamotrigine) |
|
|---|
| Stavzor (valproic acid) | Caplyta (lumateperone) | Lamictal (lamotrigine) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Bipolar Disorder, Epilepsy, Seizures, Seizure Prevention, Migraine Prevention. Stavzor may also be used for purposes not listed in this medication guide. |
Prescription only
Caplyta is an atypical antipsychotic that may be used to treat adults with schizophrenia. Sedation is the most common side effect and it should not be used in people with moderate to severe liver... View more |
Prescription only
Lamictal is used to decrease the frequency and severity of seizures in some types of epilepsy and also to stabilize mood in bipolar disorder. Rarely, Lamictal may cause a potentially fatal rash... View more |
||||||||
| More about Stavzor (valproic acid) | More about Caplyta (lumateperone) | More about Lamictal (lamotrigine) | ||||||||
| Ratings & Reviews | ||||||||||
|
Stavzor has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Caplyta has an average rating of 6.5 out of 10 from a total of 178 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 30% reported a negative effect. |
Lamictal has an average rating of 8.0 out of 10 from a total of 789 ratings on Drugs.com. 76% of reviewers reported a positive effect, while 13% reported a negative effect. |
||||||||
| Drug Class | ||||||||||
| Side Effects | ||||||||||
| Generic Availability | ||||||||||
| Lower cost generic approved | ||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Caplyta prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms Available | ||||||||||
|
N/A |
|
|
||||||||
| Brand Names | ||||||||||
| Other valproic acid brands include: Valproate Sodium |
N/A |
Other lamotrigine brands include: Lamictal CD, Lamictal ODT, Lamictal XR, Subvenite | ||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
|
16 hours |
18 hours |
25.7 hours |
||||||||
| CSA Schedule ** View glossary of terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Category D
Positive evidence of risk
When Treating Epilepsy
Category X
Not for use in pregnancy
When Treating Migraine See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 409 drugs are known to interact with Stavzor:
|
A total of 598 drugs are known to interact with Caplyta:
|
A total of 286 drugs are known to interact with Lamictal:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
|
|||||||||
| Disease Interactions | ||||||||||
| First Approval Date | ||||||||||
|
July 29, 2008 |
December 20, 2019 |
December 27, 1994 |
||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient resources | ||||||||||
| Professional Resources | ||||||||||
|
N/A |
||||||||||
| Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.